Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A. Ference, Alberico L. Catapano, Heribert Schunkert et al.|European Heart Journal|2017Cited by 3.8k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJan Borén, Henry N. Ginsberg, M. John Chapman et al.|European Heart Journal|2020Cited by 1.5k
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis SocietyHenry N. Ginsberg, Alberico L. Catapano, Chris J. Packard et al.|European Heart Journal|2021Cited by 889
Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in LifeJennifer G. Robinson, Allan D. Sniderman, Kevin Jon Williams et al.|Journal of the American Heart Association|2018Cited by 105
Genome of the Netherlands population-specific imputations identify an ABCA6 variant associated with cholesterol levelsCaroline Hayward, Lennart C. Karssen, Joris Deelen et al.|Nature Communications|2015Cited by 75